162 related articles for article (PubMed ID: 25516654)
1. Lobaplatin inhibits growth of gastric cancer cells by inducing apoptosis.
Yin CY; Lin XL; Tian L; Ye M; Yang XY; Xiao XY
World J Gastroenterol; 2014 Dec; 20(46):17426-33. PubMed ID: 25516654
[TBL] [Abstract][Full Text] [Related]
2. Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion.
Li Y; Liu B; Yang F; Yu Y; Zeng A; Ye T; Yin W; Xie Y; Fu Z; Zhao C
Biomed Pharmacother; 2016 Oct; 83():1239-1246. PubMed ID: 27565846
[TBL] [Abstract][Full Text] [Related]
3. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
[TBL] [Abstract][Full Text] [Related]
4. Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell Line CaSki.
Li X; Ran L; Fang W; Wang D
Biomed Pharmacother; 2014 Apr; 68(3):291-7. PubMed ID: 24239273
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio.
Du L; Fei Z; Song S; Wei N
Biomed Pharmacother; 2017 Nov; 95():447-452. PubMed ID: 28865364
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells.
Liu N; Tian H; Zhang G; Sun N; Wang S
Med Oncol; 2021 Nov; 39(1):16. PubMed ID: 34837558
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Mechanism of Lobaplatin as Monotherapy and in Combination with Paclitaxel in Human Gastric Cancer.
Hua S; Kong X; Chen B; Zhuang W; Sun Q; Yang W; Liu W; Zhang Y
Curr Mol Pharmacol; 2018; 11(4):316-325. PubMed ID: 30101722
[TBL] [Abstract][Full Text] [Related]
8. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro.
Dai HY; Liu L; Qin SK; He XM; Li SY
Biomed Pharmacother; 2011 Jun; 65(3):137-41. PubMed ID: 21612887
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
He J; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
[TBL] [Abstract][Full Text] [Related]
10. Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression.
Tian W; Hao S; Gao B; Jiang Y; Zhang X; Zhang S; Guo L; Zhao J; Zhang G; Chen Y; Li Z; Luo D
Drug Des Devel Ther; 2018; 12():3563-3571. PubMed ID: 30464390
[TBL] [Abstract][Full Text] [Related]
11. Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitro.
Engel JB; Martens T; Hahne JC; Häusler SF; Krockenberger M; Segerer S; Djakovic A; Meyer S; Dietl J; Wischhusen J; Honig A
Anticancer Drugs; 2012 Apr; 23(4):426-36. PubMed ID: 22314264
[TBL] [Abstract][Full Text] [Related]
12. Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal.
Chen L; Cao H; Yu C; Feng Y
Fundam Clin Pharmacol; 2018 Oct; 32(5):548-557. PubMed ID: 29733466
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
Xie CY; Xu YP; Jin W; Lou LG
Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
[TBL] [Abstract][Full Text] [Related]
14. Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro.
Yang F; Yu Y; Lei Q; Zeng A; Li Y; Xie Y; Ye T; Wei Y
Biomed Pharmacother; 2015 Feb; 69():402-8. PubMed ID: 25661389
[TBL] [Abstract][Full Text] [Related]
15. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
Harstrick A; Bokemeyer C; Scharnofkse M; Hapke G; Reile D; Schmoll HJ
Cancer Chemother Pharmacol; 1993; 33(1):43-7. PubMed ID: 8269588
[TBL] [Abstract][Full Text] [Related]
16. CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest.
Li Y; Zhang D; Yu K; Hu Y; Wu Q; Qian F; Wang Z
Biol Res; 2018 Apr; 51(1):11. PubMed ID: 29661232
[TBL] [Abstract][Full Text] [Related]
17. Preclinical activity of lobaplatin as a single agent and in combination with taxanes for ovarian carcinoma cells.
Sun X; Lou LG; Sui DH; Wu XH
Asian Pac J Cancer Prev; 2014; 15(22):9939-43. PubMed ID: 25520132
[TBL] [Abstract][Full Text] [Related]
18. Lobaplatin suppresses proliferation and peritoneal metastasis of colorectal cancer in a preclinical model.
Shan L; Bai B; Lv Y; Xie B; Huang X; Zhu H
Biomed Pharmacother; 2018 Dec; 108():486-491. PubMed ID: 30243080
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis.
Xiao XY; Hao M; Yang XY; Ba Q; Li M; Ni SJ; Wang LS; Du X
Cancer Lett; 2011 Mar; 302(1):69-75. PubMed ID: 21216524
[TBL] [Abstract][Full Text] [Related]
20. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]